150 related articles for article (PubMed ID: 35144328)
1. Diagnostic criteria of perfluorobutane-enhanced ultrasonography for diagnosing hepatocellular carcinoma in high-risk individuals: how is late washout determined?
Kang HJ; Kim JH; Yoo J; Han JK
Ultrasonography; 2022 Jul; 41(3):530-542. PubMed ID: 35144328
[TBL] [Abstract][Full Text] [Related]
2. Contrast-enhanced US with Sulfur Hexafluoride and Perfluorobutane for the Diagnosis of Hepatocellular Carcinoma in Individuals with High Risk.
Kang HJ; Lee JM; Yoon JH; Lee K; Kim H; Han JK
Radiology; 2020 Oct; 297(1):108-116. PubMed ID: 32749211
[TBL] [Abstract][Full Text] [Related]
3. Perfluorobutane-enhanced ultrasonography with a Kupffer phase: improved diagnostic sensitivity for hepatocellular carcinoma.
Hwang JA; Jeong WK; Kang HJ; Lee ES; Park HJ; Lee JM
Eur Radiol; 2022 Dec; 32(12):8507-8517. PubMed ID: 35705829
[TBL] [Abstract][Full Text] [Related]
4. Contrast-Enhanced Ultrasound With Perfluorobutane for Hepatocellular Carcinoma Diagnosis: Comparison of Imaging Phases and Diagnostic Criteria.
Kang HJ; Lee JM; Yoon JH; Yoo J; Kim JH; Park J
AJR Am J Roentgenol; 2024 Feb; 222(2):e2330156. PubMed ID: 37991335
[No Abstract] [Full Text] [Related]
5. Noninvasive Diagnosis of Hepatocellular Carcinoma on Sonazoid-Enhanced US: Value of the Kupffer Phase.
Takahashi H; Sugimoto K; Kamiyama N; Sakamaki K; Kakegawa T; Wada T; Tomita Y; Abe M; Yoshimasu Y; Takeuchi H; Itoi T
Diagnostics (Basel); 2022 Jan; 12(1):. PubMed ID: 35054309
[TBL] [Abstract][Full Text] [Related]
6. Sonazoid™ versus SonoVue
Kang HJ; Lee JM; Yoon JH; Yoo J; Choi Y; Joo I; Han JK
Korean J Radiol; 2022 Nov; 23(11):1067-1077. PubMed ID: 36196767
[TBL] [Abstract][Full Text] [Related]
7. Role of Contrast-Enhanced Ultrasound as a Second-Line Diagnostic Modality in Noninvasive Diagnostic Algorithms for Hepatocellular Carcinoma.
Kang HJ; Lee JM; Yoon JH; Han JK
Korean J Radiol; 2021 Mar; 22(3):354-365. PubMed ID: 33236540
[TBL] [Abstract][Full Text] [Related]
8. Assessment of arterial-phase hyperenhancement and late-phase washout of hepatocellular carcinoma-a meta-analysis of contrast-enhanced ultrasound (CEUS) with SonoVue® and Sonazoid®.
Ren J; Lu Q; Fei X; Dong Y; D Onofrio M; Sidhu PS; Dietrich CF
Eur Radiol; 2023 Nov; ():. PubMed ID: 37989916
[TBL] [Abstract][Full Text] [Related]
9. Can contrast enhanced ultrasound differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma?
Huang JY; Li JW; Ling WW; Li T; Luo Y; Liu JB; Lu Q
World J Gastroenterol; 2020 Jul; 26(27):3938-3951. PubMed ID: 32774068
[TBL] [Abstract][Full Text] [Related]
10. Contrast-Enhanced Ultrasound Patterns for the Non-invasive Diagnosis of Hepatocellular Carcinoma: A Prospective Multicenter Study in Histologically Proven Liver Lesions in a Real-Life Setting Demonstrating the Benefit of Extended Late Phase Observation.
Schellhaas B; Bernatik T; Dirks K; Jesper D; Mauch M; Potthoff A; Zimmermann P; Strobel D
Ultrasound Med Biol; 2021 Nov; 47(11):3170-3180. PubMed ID: 34417066
[TBL] [Abstract][Full Text] [Related]
11. Perfluorobutane-Enhanced Ultrasound for Characterization of Hepatocellular Carcinoma From Non-hepatocellular Malignancies or Benignancy: Comparison of Imaging Acquisition Methods.
Han S; Kim SW; Park S; Yoon JH; Kang HJ; Yoo J; Joo I; Bae JS; Lee JM
Ultrasound Med Biol; 2023 Oct; 49(10):2256-2263. PubMed ID: 37495497
[TBL] [Abstract][Full Text] [Related]
12. Imaging appearance of residual HCC following incomplete trans-arterial chemoembolization on contrast-enhanced imaging.
Polikoff A; Wessner CE; Balasubramanya R; Dulka S; Liu JB; Machado P; Savsani E; Lyshchik A; Shaw CM; Eisenbrey JR
Abdom Radiol (NY); 2022 Jan; 47(1):152-160. PubMed ID: 34643782
[TBL] [Abstract][Full Text] [Related]
13. Added Value of sequentially performed gadoxetic acid-enhanced liver MRI for the diagnosis of small (10-19 mm) or atypical hepatic observations at contrast-enhanced CT: A prospective comparison.
Yoon JH; Lee JM; Lee YJ; Lee KB; Han JK
J Magn Reson Imaging; 2019 Feb; 49(2):574-587. PubMed ID: 30102433
[TBL] [Abstract][Full Text] [Related]
14. Extended application of subtraction arterial phase imaging in LI-RADS version 2018: a strategy to improve the diagnostic performance for hepatocellular carcinoma on gadoxetate disodium-enhanced MRI.
Kim SS; Lee S; Bae H; Chung YE; Choi JY; Park MS; Kim MJ
Eur Radiol; 2021 Mar; 31(3):1620-1629. PubMed ID: 32886205
[TBL] [Abstract][Full Text] [Related]
15. Distinguishing intrahepatic cholangiocarcinoma from hepatocellular carcinoma in patients with and without risks: the evaluation of the LR-M criteria of contrast-enhanced ultrasound liver imaging reporting and data system version 2017.
Li F; Li Q; Liu Y; Han J; Zheng W; Huang Y; Zheng X; Cao L; Zhou JH
Eur Radiol; 2020 Jan; 30(1):461-470. PubMed ID: 31297632
[TBL] [Abstract][Full Text] [Related]
16. Intra-individual comparison of dual portal venous phases for non-invasive diagnosis of hepatocellular carcinoma at gadoxetic acid-enhanced liver MRI.
Kang HJ; Lee JM; Jeon SK; Jang S; Park S; Joo I; Yoon JH; Han JK
Eur Radiol; 2021 Feb; 31(2):824-833. PubMed ID: 32845387
[TBL] [Abstract][Full Text] [Related]
17. Contrast-Enhanced Ultrasound for the Characterization of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
Liu GJ; Wang W; Lu MD; Xie XY; Xu HX; Xu ZF; Chen LD; Wang Z; Liang JY; Huang Y; Li W; Liu JY
Liver Cancer; 2015 Dec; 4(4):241-52. PubMed ID: 26779444
[TBL] [Abstract][Full Text] [Related]
18. Differentiation between hepatocellular carcinoma and intrahepatic cholangiocarcinoma using contrast-enhanced ultrasound: A systematic review and meta-analysis.
Chen Y; Zhu Y; Chen K; Wang H; Zhang W; Bao J; Wang W
Clin Hemorheol Microcirc; 2021; 79(2):293-309. PubMed ID: 33935070
[TBL] [Abstract][Full Text] [Related]
19. Additional value of contrast-enhanced ultrasound (CEUS) on arterial phase non-hyperenhancement observations (≥ 2 cm) of CT/MRI for high-risk patients: focusing on the CT/MRI LI-RADS categories LR-3 and LR-4.
Kang HJ; Kim JH; Joo I; Han JK
Abdom Radiol (NY); 2020 Jan; 45(1):55-63. PubMed ID: 31332503
[TBL] [Abstract][Full Text] [Related]
20. Pathological considerations of CEUS LI-RADS: correlation with fibrosis stage and tumour histological grade.
Cheng MQ; Hu HT; Huang H; Pan JM; Xian MF; Huang Y; Kuang M; Xie XY; Li W; Wang W; Lu MD
Eur Radiol; 2021 Aug; 31(8):5680-5688. PubMed ID: 33502556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
